35 results
Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study

Thumbnail

D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis

Thumbnail

D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial

Thumbnail

D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to

Thumbnail

D2.499 - Immunoregulatory Effects of Dupilumab Added to Omalizumab-Facilitated Multi-Allergen Oral Immunotherapy in the COMBINE clinical trial

Thumbnail

D2.503 - LP-003 Injection for the treatment of H1 Antihistamine-Inadequately Controlled Chronic Spontaneous Urticaria (CSU): A Multicenter, Randomized, Double-Blind, Controlled Phase Ⅱ Study

Thumbnail

D2.504 - Novel food supplement containing a combination of bioactive compounds in pediatric cow’s milk protein allergy: results from a randomized, placebo-controlled trial

Thumbnail

D3.274 - Feasibility of Digestive Enzyme Supplementation for Cow’s Milk Allergy in Exclusively Breastfed Infants

Thumbnail

D3.270 - Recent Trends in Food Allergy among Schoolchildren in a South Korean City (2018–2022)

Thumbnail

D3.271 - Development of a multiplex assay to assess the risk of IgE cross-reactivity to new protein sources

Thumbnail

D3.272 - Selective Sensitization to Prawn with Absence of Cross-Reactivity to Fish: Molecular Identification of Hemocyanin (Pen m 7) and Sarcoplasmic Calcium-Binding Protein (Pen m 4) in a Patient with Recurrent Urticaria

Thumbnail

D3.273 - Longitudinal Changes in Severity in Children with Severe, Refractory Cow’s Milk Allergy

Thumbnail

D3.275 - In silico based assessment of intrinsic protein features for ranking clinical relevance of plant-based food allergens

Thumbnail

D3.277 - Tolerance to canned fish in patients allergic to β -parvalbumins

Thumbnail

D3.278 - Tropomyosin-Driven Cross-Reactivity Between Shellfish and House Dust Mites: A Case Report

Thumbnail

D3.279 - SWEET HONEY AND SOUR ALLERGIES: POLLEN-FOOD DEFENSIN CROSS-REACTIVITY - a case series